Aurinia Pharmaceuticals AUPH D&A

D&A at other companies

Rogers CorporationROG

$13.2M-5.0%

Vera TherapeuticsVERA

$140K+64.7%

ANI PharmaceuticalsANIP

$19.64M-15.6%

Ultragenyx PharmaceuticalRARE

$8M-11.1%

Theravance BiopharmaTBPH

$381K-7.7%

Opko HealthOPK

$22.41M-2.7%

FAQ

What is Aurinia Pharmaceuticals's D&A?

Aurinia Pharmaceuticals (AUPH) reported D&A of $4.83M in Q2 2026.

How has Aurinia Pharmaceuticals's D&A changed year-over-year?

Aurinia Pharmaceuticals's D&A decreased by 0.6% year-over-year, from $4.86M to $4.83M.

What is the long-term trend for Aurinia Pharmaceuticals's D&A?

Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's D&A has grown at a 80.8% compound annual growth rate (CAGR), from $1.82M to $19.45M.

What does D&A mean?

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.